These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. Keshari KR; Sai V; Wang ZJ; Vanbrocklin HF; Kurhanewicz J; Wilson DM J Nucl Med; 2013 Jun; 54(6):922-8. PubMed ID: 23575993 [TBL] [Abstract][Full Text] [Related]
4. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Albers MJ; Bok R; Chen AP; Cunningham CH; Zierhut ML; Zhang VY; Kohler SJ; Tropp J; Hurd RE; Yen YF; Nelson SJ; Vigneron DB; Kurhanewicz J Cancer Res; 2008 Oct; 68(20):8607-15. PubMed ID: 18922937 [TBL] [Abstract][Full Text] [Related]
5. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. Zierhut ML; Yen YF; Chen AP; Bok R; Albers MJ; Zhang V; Tropp J; Park I; Vigneron DB; Kurhanewicz J; Hurd RE; Nelson SJ J Magn Reson; 2010 Jan; 202(1):85-92. PubMed ID: 19884027 [TBL] [Abstract][Full Text] [Related]
6. The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate. Billingsley KL; Park JM; Josan S; Hurd R; Mayer D; Spielman-Sun E; Nishimura DG; Brooks JD; Spielman D Magn Reson Imaging; 2014 Sep; 32(7):791-5. PubMed ID: 24907854 [TBL] [Abstract][Full Text] [Related]
7. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Chen AP; Albers MJ; Cunningham CH; Kohler SJ; Yen YF; Hurd RE; Tropp J; Bok R; Pauly JM; Nelson SJ; Kurhanewicz J; Vigneron DB Magn Reson Med; 2007 Dec; 58(6):1099-106. PubMed ID: 17969006 [TBL] [Abstract][Full Text] [Related]
8. Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. Keshari KR; Wilson DM; Chen AP; Bok R; Larson PE; Hu S; Van Criekinge M; Macdonald JM; Vigneron DB; Kurhanewicz J J Am Chem Soc; 2009 Dec; 131(48):17591-6. PubMed ID: 19860409 [TBL] [Abstract][Full Text] [Related]
9. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Lupo JM; Chen AP; Zierhut ML; Bok RA; Cunningham CH; Kurhanewicz J; Vigneron DB; Nelson SJ Magn Reson Imaging; 2010 Feb; 28(2):153-62. PubMed ID: 19695815 [TBL] [Abstract][Full Text] [Related]
10. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. Chen HY; Larson PEZ; Bok RA; von Morze C; Sriram R; Delos Santos R; Delos Santos J; Gordon JW; Bahrami N; Ferrone M; Kurhanewicz J; Vigneron DB Cancer Res; 2017 Jun; 77(12):3207-3216. PubMed ID: 28428273 [TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Keshari KR; Sriram R; Van Criekinge M; Wilson DM; Wang ZJ; Vigneron DB; Peehl DM; Kurhanewicz J Prostate; 2013 Aug; 73(11):1171-81. PubMed ID: 23532911 [TBL] [Abstract][Full Text] [Related]
12. Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine. Canapè C; Catanzaro G; Terreno E; Karlsson M; Lerche MH; Jensen PR Magn Reson Med; 2015 Jun; 73(6):2296-305. PubMed ID: 25045880 [TBL] [Abstract][Full Text] [Related]
13. Hyperpolarized 13C MR for molecular imaging of prostate cancer. Wilson DM; Kurhanewicz J J Nucl Med; 2014 Oct; 55(10):1567-72. PubMed ID: 25168625 [TBL] [Abstract][Full Text] [Related]